inCerebro

inCerebro is at the forefront of pharmaceutical manufacturing, dedicated to pioneering next-generation drug discovery technology through a quantum-driven approach. The company's innovative MIND platform is uniquely engineered to identify novel small molecule therapeutics, targeting difficult-to-reach targets such as GPCRs and previously intractable protein targets. inCerebro's platform integrates key technologies like QM/MM docking, Water pharmacophore, and binding free energy calculations, offering cost-saving and time-efficient solutions for early drug discovery.

inCerebro prides itself on a team of world-renowned scientists and industry leaders specializing in physics-based computational platforms and machine learning technologies. The company provides its cutting-edge technology both as a drug discovery service and as the MIND platform, accelerating hit identification and lead optimization. inCerebro is located at 서울시 강남구 테헤란로10길 8.

We invite partners interested in investing, co-developing pipelines, or integrating our physics and AI-based drug discovery platform to connect with inCerebro. We are actively enhancing our platform and encourage you to return soon for the latest updates from our management team. To the manager of inCerebro, we cordially invite you to create a customized and exclusive company showcase and product listing on our platform.